As expected, the sensitivity of ColoC‐mSTEM to the early stage of CRC (especially stage I‐II) and high‐grade AA was significantly higher than that of conventional clinical detection markers (CEA, CA19‐9). The gene discussed is CEACAM5; the disease is colorectal carcinoma.